News & Updates

Study reveals genomic landscape of KRAS G12C mutations in Chinese patients

08 Sep 2020 by

A recent study involving 11,951 tumour samples has revealed the genomic landscape of KRAS G12C mutations in Chinese patients.

Study reveals genomic landscape of KRAS G12C mutations in Chinese patients

08 Sep 2020

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

07 Sep 2020 by

A small study conducted in Iran suggests a role for sofosbuvir-daclatasvir in the treatment of moderate-to-severe COVID-19.

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

07 Sep 2020

Poorly absorbable antibiotics do not affect hepatic venous pressure gradient

07 Sep 2020

Neither rifaximin nor norfloxacin, both poorly absorbable antibiotics, significantly reduces hepatic venous pressure gradient in patients with portal hypertension and cirrhosis, a recent study has found.

Poorly absorbable antibiotics do not affect hepatic venous pressure gradient

07 Sep 2020

Trivalent hep B vaccine yields robust immune response

07 Sep 2020 by

A trivalent vaccine against hepatitis (hep B) is safe and effectively elicits robust immune response compared with a monovalent Hep B vaccine, according to the PROTECT and CONSTANT studies presented during the 2020 digital ILC.

Trivalent hep B vaccine yields robust immune response

07 Sep 2020

Novel lipid-lowering drug halts development, progression of diabetes

07 Sep 2020

Bempedoic acid, a novel drug used to lower the bad cholesterol, reduces the risk of developing new-onset diabetes or its progression, according to the results of a meta-analysis.

Novel lipid-lowering drug halts development, progression of diabetes

07 Sep 2020

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

07 Sep 2020

Trabecular bone loss is longitudinally associated with Ankylosing Spondylitis Disease Activity Score (ASDAS) and inflammatory markers in patients with axial spondyloarthritis (axSpA), a study has found.

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

07 Sep 2020

Cardiac time intervals predict MACE in T1D patients without heart disease

07 Sep 2020 by

In patients with type 1 diabetes (T1D) without known heart disease, cardiac time intervals positively correlate with major adverse cardiovascular events (MACE), according to a study presented at the ESC Congress 2020: The Digital Experience.

Cardiac time intervals predict MACE in T1D patients without heart disease

07 Sep 2020

Adopting a healthy lifestyle lowers risk of symptomatic gallstone disease

07 Sep 2020

A healthy lifestyle pattern, especially maintaining a healthy weight, may lower the risk of developing symptomatic gallstone diseases, as indicated by findings from two large prospective studies.

Adopting a healthy lifestyle lowers risk of symptomatic gallstone disease

07 Sep 2020

Mavacamten: First targeted treatment for obstructive hypertrophic cardiomyopathy?

07 Sep 2020 by

Mavacamten, a first-in-class myosin inhibitor, may be the first targeted therapy to address the underlying cause of obstructive hypertrophic cardiomyopathy (OHCM), the EXPLORER-HCM trial has shown.

Mavacamten: First targeted treatment for obstructive hypertrophic cardiomyopathy?

07 Sep 2020

NAFLD remains a top public health threat

07 Sep 2020 by

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver-related deaths and is associated with a variety of malignancies, according to a new study presented at the Digital International Liver Congress (ILC) 2020.

NAFLD remains a top public health threat

07 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Study reveals genomic landscape of KRAS G12C mutations in Chinese patients

Study reveals genomic landscape of KRAS G12C mutations in Chinese patients

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

Does sofosbuvir-daclatasvir have a role in COVID-19 management?

Poorly absorbable antibiotics do not affect hepatic venous pressure gradient

Poorly absorbable antibiotics do not affect hepatic venous pressure gradient

Trivalent hep B vaccine yields robust immune response

Trivalent hep B vaccine yields robust immune response

Novel lipid-lowering drug halts development, progression of diabetes

Novel lipid-lowering drug halts development, progression of diabetes

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

Cardiac time intervals predict MACE in T1D patients without heart disease

Cardiac time intervals predict MACE in T1D patients without heart disease

Adopting a healthy lifestyle lowers risk of symptomatic gallstone disease

Adopting a healthy lifestyle lowers risk of symptomatic gallstone disease

Mavacamten: First targeted treatment for obstructive hypertrophic cardiomyopathy?

Mavacamten: First targeted treatment for obstructive hypertrophic cardiomyopathy?

NAFLD remains a top public health threat

NAFLD remains a top public health threat